The much-awaited NSE IPO has moved into its final stage, with allotment now completed and shares scheduled to list on the BSE on September 24, 2026. The ₹22,561.57-crore issue attracted strong interest, receiving 5.71 times overall subscription during its September 17–21 bidding window.
The numbers are impressive, but the real significance of the National Stock Exchange IPO goes beyond the immediate listing-day excitement. The issue was priced at ₹1,700–₹1,785 per share, with a lot size of eight shares. The IPO was entirely an offer for sale involving 12.64 crore shares.
GMP Should Not Become Main Story
Much of the attention around the NSE IPO has focused on its grey market premium (GMP). As of September 23, the reported GMP stood at ₹43, implying an indicative listing price of around ₹1,828 against the upper issue price of ₹1,785. That translates into an indicative premium of 2.41%.
However, GMP is an unofficial market indicator, not a guarantee of the actual listing price. The final price will depend on buying and selling demand once NSE shares begin trading on the BSE. This distinction is particularly important when IPO excitement can encourage investors to focus excessively on short-term listing gains.
Bigger NSE IPO Question
The NSE IPO also offers a broader perspective on India's capital markets. The exchange itself occupies a central position in the country's equity ecosystem, making its public-market debut a closely watched event.
Yet an IPO should ultimately be viewed beyond the first trading session. Investors may need to consider valuation, business fundamentals, regulatory developments, market conditions and long-term earnings potential rather than relying solely on subscription figures or GMP.
The NSE listing is undoubtedly a landmark market event. But the more meaningful test will begin after the listing-day headlines fade.